Cymogen Dx, based in New Windsor, NY, is a leading provider of innovative FISH probes and reagents designed to aid in the identification of genomic aberrations in various cancers, including hematologic and solid tumors. Their proprietary FISH Probe technology, combined with advanced cell isolation techniques, offers unparalleled analytical accuracy for Formalin Fixed, Paraffin Embedded (FFPE) specimens.
The company's patent-pending Deletion Detection Probe technology and FFPE platform are at the forefront of detecting genomic changes with exceptional precision, setting them apart in the field of cancer research. With a focus on providing high-quality, color-coded FISH probes and cutting-edge labeling systems, Cymogen Dx is dedicated to advancing the understanding and study of chromosomal abnormalities in cancer cells.
Generated from the website